You just read:

ProMetic's PBI-4050 Demonstrates Early Evidence of Efficacy in its Idiopathic Pulmonary Fibrosis ("IPF") Phase 2 Clinical Trial

News provided by

ProMetic Life Sciences Inc.

Nov 17, 2016, 07:24 ET